The global neuroprosthetics market is expected to grow at a CAGR of 12.91%, reaching a market size of US$14.927 billion in 2030 from US$8.645 billion in 2025. Neuroprosthetics is a type of prosthetics device, that...
The global neuroprosthetics market is expected to grow at a CAGR of 12.91%, reaching a market size of US$14.927 billion in 2030 from US$8.645 billion in 2025.
Neuroprosthetics is a type of prosthetics device, that integrates biomedicine and neuroscience. A major purpose of neuroprosthetics is to restore the sensory, cognitive, and motor functions of patients. The neuroprosthetics interface with the spinal or brain circuits, which helps in enhancing the body's functionality. The major function of neuroprosthetic devices is to restore the motor functionality of paralyzed patients. The global neuroprosthetics market is expected to witness significant growth with the growing global cases of neurological disorders. The global cases of neurological disorders in the past few years have witnessed significant growth. The World Health Organization, in its report, stated that about 1 in every 3 individuals in the globe is affected by some type of neurological disease. Similarly, the World Federation of Neurology in its paper stated that as of 2023, about 40% of the total global population suffers from neurological conditions. The federation further stated that Stroke, Neonatal encephalopathy, Migraine, Dementia, and Meningitis are among the most common neurological disorders prevailing across the globe.
With the rising global demand for neuroprosthetics devices, various research organizations have increased their research and development investment in the market. For instance, the RICE University and Houston Methodist in January 2024, launched the Center for Neural System Restoration, which is aimed to enhance neuroscience research and treatment innovations. Similarly, in March 2022, the University of Alabama at Birmingham (UAB) launched the Neuroengineering and Brain-Computer Interface Initiative.
The type segment of the global neuroprosthetics market is categorized into output neural prosthetics and input neural prosthetics. The output neural prosthetics category of the type segment is estimated to attain a greater market share in the global neuroprosthetics market during the forecasted timeline. The output neural prosthetics devices are a type of neuroprosthetic device, which enhances the output of the neural system.
By technique, the global neuroprosthetics market is segmented into deep brain stimulation, spinal cord stimulation, sacral nerve stimulation, transcranial magnetic stimulation, and vague nerve stimulation. Under the technique segment, the deep brain stimulation category is forecasted to witness significant growth in the global neuroprosthetics market. Deep brain stimulation or DBS is a type of neurosurgical procedure, which is used to implant electrodes and electrical stimulation. The DBS technique is used for the treatment of Parkinson's disease, dystonia, and other type of neurological disorders.
The global neuroprosthetics market, under the application segment, is categorized into auditory processing disorders, Parkinson's disease, epilepsy, ophthalmic disease, cardiovascular disease, paralysis, Alzheimer's disease, and others. The Parkinson's disease category of the application segment in the global neuroprosthetics market is expected to grow at a significant rate. Parkinson's disease is a neurological disease, in which the part of the brain deteriorates which causes severe neurological symptoms. The global cases of Parkinson's disease witnessed an increase, with over 1 million individuals living with Parkinson's disease in the USA, and about 90,000 individuals being diagnosed with the disease every year, as stated by the Parkinson's Foundation.
Based on geography, the European region is expected to witness significant growth in the global neuroprosthetics market. The North American region is among the global leaders in neurological and pharmaceutical technology leader. The governments of multiple countries, especially the USA and Canada have also introduced key policies and investment schemes to boost the research and development investment in the region.
As a part of the report, the major players operating in the global neuroprosthetics market that have been covered are SenArs, LivaNova PLC, Medtronic PLC, Sonova Holding AG, Boston Scientific Corporation, Cochlear Ltd, Demant AS, Abbott Laboratories, NeuroPace, Inc., BrainGate, and NDI Medical.
View a sample of the report or purchase the complete study at: https://www.knowledge-sourcing.com/report/global-neuroprosthetics-marketThe market analytics report segments the global neuroprosthetics market as follows:
- By Type
- Output Neural Prosthetics
- Input Neural Prosthetics
- By Technique
- Deep Brain Stimulation
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
- Transcranial Magnetic Stimulation
- Vague Nerve Stimulation
- By Application
- Auditory Processing Disorders
- Parkison’s Disease
- Epilepsy
- Ophthalmic Disease
- Cardiovascular Disease
- Paralysis
- Alzheimer's Disease
- Others
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- United Kingdom
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others
- North America
- Prosthetic Arm Market
- Dental Implant and Prosthetics Market
- Neurorehabilitation Market
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.